http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110917219-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-74 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-135 |
| filingDate | 2019-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110917219-B |
| titleOfInvention | Application of parabacteroides goehrlii in preparation of pharmaceutical composition for preventing and/or treating chronic obstructive pulmonary disease |
| abstract | The invention relates to the field of microorganisms, in particular to application of parabacteroides gomerdae in preparing a medicinal composition for preventing and/or treating chronic obstructive pulmonary disease. The parabacteroides gomersii with the deposit number of DSM32939 can improve weight loss, emphysema, infiltration of inflammatory cells in lung tissue, thickening and hyperplasia of tracheal wall, pulmonary fibrosis and lung dysfunction of animals or human caused by chronic obstructive pulmonary disease, and can also regulate the expression of genes related to lung fibrosis and mitochondrial activity in lung tissue. Therefore, the compound can be used for treating chronic obstructive pulmonary disease and the preparation of related pharmaceutical compositions. |
| priorityDate | 2018-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 119.